News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix Inc
(NQ:
BDSX
)
1.720
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix Inc
< Previous
1
2
3
4
5
6
7
Next >
Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors
December 08, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer
November 18, 2021
From
Biodesix, Inc.
Via
Business Wire
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
August 18, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer
December 01, 2021
From
Biodesix
Via
Business Wire
Biodesix, Inc. (BDSX) Q3 2021 Earnings Call Transcript
November 16, 2021
BDSX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biodesix Announces Third Quarter 2021 Results and Highlights
November 15, 2021
From
Biodesix, Inc.
Via
Business Wire
Earnings Scheduled For August 10, 2021
August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:
Via
Benzinga
Biodesix to Present Data Supporting Proteomic-Based Immunotherapy Diagnostic Tests and AI Explainability in Diagnostic Tests at Society for Immunotherapy of Cancer Annual Meeting
November 12, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 11, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021
November 01, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting
October 13, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix's Return On Capital Employed Insights
September 22, 2021
Biodesix (NASDAQ:BDSX) brought in sales totaling $11.88 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 89.63%, resulting in a loss of $...
Via
Benzinga
Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer
September 16, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
September 02, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American Pathologists
August 25, 2021
From
Biodesix, Inc.
Via
Business Wire
4 Stocks Insiders Are Buying
August 24, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...
Via
Benzinga
66 Biggest Movers From Yesterday
August 18, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
66 Biggest Movers From Yesterday
August 12, 2021
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why Did Biodesix Stock Fall 26% Today?
August 11, 2021
Biodesix Inc's (NASDAQ: BDSX) second-quarter revenues grew 183% Y/Y to $11.9 million, but short of the $21.14 million consensus. COVID-19 testing revenues...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Intraday Session
August 11, 2021
Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
Biodesix, Inc. (BDSX) Q2 2021 Earnings Call Transcript
August 10, 2021
BDSX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Biodesix Announces Second Quarter 2021 Results and Highlights
August 10, 2021
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
August 02, 2021
From
Biodesix, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
July 27, 2021
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.